Every SEC Form 3/4/5 on record for this filer (CIK 1824386) — 2 issuers, 11 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| INVA | Innoviva, Inc. | See Remarks · lapsed | 2024-01-10 → 2024-05-21 | 5 | — |
| ETTX | Entasis Therapeutics Holdings Inc. | Chief of Pharma Sciences & MFG · lapsed | 2020-09-11 → 2022-07-11 | 7 | −$11,991 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ETTX | 2021-10-19 | Sell | 3,759 | $3.19 | $11,991 | 46,241 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.